Yonghong Bai
About Yonghong Bai
Yonghong Bai is a Director at MOMA Therapeutics in Cambridge, Massachusetts, where he has worked since 2023. He has an extensive background in bioengineering, holding a PhD from the University of Missouri-Columbia and has held various scientific roles at notable institutions including Amgen and Baylor College of Medicine.
Work at MOMA Therapeutics
Yonghong Bai currently serves as Director at MOMA Therapeutics, a position he has held since 2023. His role is based in Cambridge, Massachusetts. Prior to this, he worked as Principal Scientist at the same organization from 2020 to 2022. In these roles, he has contributed to the company's mission of advancing therapeutic solutions.
Education and Expertise
Yonghong Bai earned a PhD in Bioengineering from the University of Missouri-Columbia, where he studied from 2007 to 2012. He also holds a Bachelor of Science in Biomedical Engineering from Zhejiang University, completed between 2002 and 2007. His educational background provides a strong foundation for his work in the biotechnology field.
Professional Background
Yonghong Bai has a diverse professional background in the biotechnology sector. He has held various positions, including Senior Scientist and Group Lead at Amgen from 2019 to 2020, and Scientist at Amgen from 2015 to 2019. His experience also includes roles as a Postdoctoral Associate at Baylor College of Medicine and a Postdoc Research Scientist at Columbia University.
Consulting Experience
In 2020, Yonghong Bai worked as a Consultant at Third Rock Ventures for a brief period of one month. This role added to his extensive experience in the biotechnology and pharmaceutical industries, showcasing his ability to provide expert insights and guidance.
Research Contributions
Throughout his career, Yonghong Bai has engaged in significant research activities. He worked as a Graduate Research Assistant at the University of Missouri-Columbia from 2007 to 2012, contributing to various projects during his studies. His research experience spans multiple institutions and roles, reflecting his commitment to advancing scientific knowledge.